The investigators through JQ1 or siBRD4 reduced the expression of BRD4 favoring a reduction of the expression of 3 major oncogenes, which are overexpressed in PAH: nuclear factor of activated T cells, B-cell lymphoma 2, and survivin. Here, BRD4 is linked to pulmonary arterial hypertension.